RemedyBio’s CSO Dr. Paul Leonard is leading an independent validation study of commercially available COVID-19 serological tests, with the aim of recommending the best in class tests for nationwide seroprevalence studies in Ireland. This project is funded by DCU’s COVID-19 Research and Innovation Hub.
Recommended For You
RemedyBio today announces a research and evaluation agreement with GSK
Remedy BiologicsDecember 13, 2022
RemedyBio announces participation in INSPIRE and successful grant funding
Remedy BiologicsDecember 6, 2022
Remedy Biologics announces collaboration to explore active TIL therapies in genitourinary cancers.
Remedy BiologicsOctober 10, 2022